Td Private Client Wealth LLC Regeneron Pharmaceuticals, Inc. Transaction History

Td Private Client Wealth LLC

  • $4.07 Trillion
  • Q2 2025

A detailed history of Td Private Client Wealth LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 108 shares of REGN stock, worth $60,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108
Previous 127 14.96%
Holding current value
$60,332
Previous $80.5 Million 29.61%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 15, 2025
SELL
$483.07 - $625.6 $9,178 - $11,886
-19 Reduced 14.96%
108 $56.7 Million
Q1 2025

Apr 29, 2025
SELL
$634.14 - $744.83 $27,902 - $32,772
-44 Reduced 25.73%
127 $80.5 Million
Q4 2024

Feb 11, 2025
BUY
$701.85 - $1046.91 $10,527 - $15,703
15 Added 9.62%
171 $122 Million
Q3 2024

Nov 18, 2024
BUY
$1024.09 - $1201.76 $7,168 - $8,412
7 Added 4.7%
156 $164 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $131,596 - $159,607
149 New
149 $157 Million
Q1 2024

Aug 16, 2024
BUY
$902.69 - $993.35 $18,053 - $19,867
20 Added 14.6%
157 $151 Million
Q4 2023

Aug 16, 2024
BUY
$775.18 - $881.7 $3,875 - $4,408
5 Added 3.79%
137 $120 Million
Q3 2023

Aug 16, 2024
SELL
$692.45 - $844.37 $2,769 - $3,377
-4 Reduced 2.94%
132 $109 Million
Q2 2023

Aug 16, 2024
SELL
$700.03 - $830.35 $7,000 - $8,303
-10 Reduced 6.85%
136 $97.7 Million
Q1 2023

Aug 16, 2024
BUY
$680.49 - $826.97 $2,721 - $3,307
4 Added 2.82%
146 $120 Million
Q4 2022

Aug 16, 2024
SELL
$705.89 - $766.39 $4,941 - $5,364
-7 Reduced 4.7%
142 $102 Million
Q3 2022

Aug 16, 2024
BUY
$573.97 - $724.32 $18,941 - $23,902
33 Added 28.45%
149 $103 Million
Q2 2022

Aug 16, 2024
SELL
$548.35 - $738.84 $22,482 - $30,292
-41 Reduced 26.11%
116 $68.6 Million
Q1 2022

Aug 16, 2024
BUY
$595.12 - $698.43 $13,687 - $16,063
23 Added 17.16%
157 $110 Million
Q4 2021

Aug 16, 2024
BUY
$543.48 - $670.97 $20,652 - $25,496
38 Added 39.58%
134 $84.6 Million
Q3 2021

Aug 16, 2024
SELL
$574.03 - $680.96 $30,423 - $36,090
-53 Reduced 35.57%
96 $58.1 Million
Q2 2021

Aug 16, 2024
BUY
$472.8 - $558.54 $15,129 - $17,873
32 Added 12.8%
282 $158 Million
Q1 2021

Aug 16, 2024
BUY
$446.73 - $548.2 $37,078 - $45,500
83 Added 49.7%
250 $118 Million
Q4 2020

Aug 16, 2024
SELL
$478.3 - $607.98 $18,653 - $23,711
-39 Reduced 18.93%
167 $80.7 Million
Q3 2020

Aug 16, 2024
SELL
$544.75 - $658.21 $13,618 - $16,455
-25 Reduced 10.82%
206 $115 Million
Q2 2020

Aug 16, 2024
SELL
$493.32 - $643.92 $8,879 - $11,590
-18 Reduced 7.23%
231 $144 Million
Q1 2020

Aug 16, 2024
BUY
$336.18 - $494.43 $50,090 - $73,670
149 Added 149.0%
249 $122 Million
Q4 2019

Aug 16, 2024
SELL
$274.13 - $376.51 $13,432 - $18,448
-49 Reduced 32.89%
100 $37.5 Million

Others Institutions Holding REGN

# of Institutions
1,449
Shares Held
84.8M
Call Options Held
1.4M
Put Options Held
1.42M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $59.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email